RESMED CDI 10:1
37.22
13-January-25 23:10:54
20 minutes delayed
Stocks
-0.54
-1.43%
Today's range
36.99 - 37.43
ISIN
AU000000RMD6
Source
ASX
-
Wallace Advisory Group LLC Invests $577,000 in EPAM Systems, Inc. (NYSE:EPAM)
14 Jan 2025 07:36:16 By Buzz FX
-
Value Line, Inc. (NASDAQ:VALU) Short Interest Update
14 Jan 2025 07:36:16 By Buzz FX
-
Cummins (NYSE:CMI) Upgraded to "Neutral" at Bank of America
14 Jan 2025 07:36:16 By Buzz FX
-
Deutsche Bank Aktiengesellschaft Initiates Coverage on EastGroup Properties (NYSE:EGP)
14 Jan 2025 07:36:16 By Buzz FX
-
Element Solutions' (ESI) Neutral Rating Reaffirmed at Bank of America
14 Jan 2025 07:36:16 By Buzz FX
-
Barclays Forecasts Strong Price Appreciation for SolarEdge Technologies (NASDAQ:SEDG) Stock
14 Jan 2025 07:36:16 By Buzz FX
-
Tempus AI (NASDAQ:TEM) Receives Buy Rating from Needham & Company LLC
14 Jan 2025 07:36:16 By Buzz FX
-
Boyd Gaming (NYSE:BYD) Price Target Raised to $85.00 at Truist Financial
14 Jan 2025 07:36:16 By Buzz FX
-
Choice Hotels International (NYSE:CHH) Receives "Underweight" Rating from Morgan Stanley
14 Jan 2025 07:36:16 By Buzz FX
-
Traders Target Rare Gap in Fed-ECB Paths to Juice Credit Returns
14 Jan 2025 07:30:16 By Buzz FX
-
Robust US Economy May Not Need Trump's Big Reforms | Newsmax.com
14 Jan 2025 07:25:28 By Buzz FX
-
14 Jan 2025 07:21:27 By Buzz FX
-
Quantum-Si (NASDAQ:QSI) Given Buy Rating at HC Wainwright
14 Jan 2025 07:16:16 By Buzz FX
-
94,178 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by 180 Wealth Advisors LLC
14 Jan 2025 07:16:16 By Buzz FX
-
Barclays Increases Netflix (NASDAQ:NFLX) Price Target to $715.00
14 Jan 2025 07:16:16 By Buzz FX
-
Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from Needham & Company LLC
14 Jan 2025 07:16:16 By Buzz FX
-
Telsey Advisory Group Reaffirms "Market Perform" Rating for European Wax Center (NASDAQ:EWCZ)
14 Jan 2025 07:16:16 By Buzz FX
-
14 Jan 2025 07:16:16 By Buzz FX
-
HC Wainwright Reiterates "Buy" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)
14 Jan 2025 07:16:16 By Buzz FX
-
Corvus Pharmaceuticals (NASDAQ:CRVS) Receives "Buy" Rating from HC Wainwright
14 Jan 2025 07:16:16 By Buzz FX